Mirxes
mirxes.com
As featured in
View 1 job
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Overview
Mirxes develops RNA-based early cancer detection tests, including a blood test for gastric cancer. Its diagnostics are built on microRNA biomarker research. The company is headquartered in Singapore.
News
觅瑞配售股票集资近1.15亿元 进行并购研发与拓展市场
在香港上市的新加坡生物科技公司觅瑞MiRXES配售近2189万股集资约7亿1100万港元近1亿1498万新元来进行并购与研发活动、拓展市场等
Read more
Report
新加坡医药公司觅瑞产品在中国获批用于胃癌早筛
本地生物科技公司觅瑞Mirxes旗下产品GASTROClear已获中国国家药品监督管理局批准成为中国首个获批用于胃癌筛查的非侵入性血液检测产品
Read more
Report
Report
AStar biotech spin-off Mirxes trims losses to US$28.4 million as top line grows
Higher revenue is driven by increased contributions from its early detection and precision multi-omics segment Read more at The Business Times.
Read more
Report
Singaporean biotech firm Mirxes lays out profitability timeline
Lihan Zhou, CEO of Mirxes, talks about the biotech company's path to profitability, He also addresses opportunities from Mirxes' inclusion on the Hang Seng Composite Index.
Read more
Report
Pro access
Upgrade to see all 27 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Growth
Hiring Momentum
48/100
Stable
Open positions
11
0 opened / 0 closed in 30 days
ATS activity
Every ~3 hours
09/06/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
100% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Singapore
Singapore
HQ
8 Biomedical Grove#02-01/04 NeurosSingapore 138665
Singapore 138665
Jobs
Apply